Volume 12 (2012) - March 2012
M Hassan Murad, Ahmad Hazem, Fernando Coto-Yglesias, Svitlana Dzyubak, Shabnum Gupta, Irina Bancos, Melanie A Lane, Patricia J Erwin, Lars Berglund, Tarig Elraiyah, Victor M Montori BMC Endocrine Disorders 2012, 12:2 (31 March 2012)
A meta-analysis of data from observational studies indicates that there is a strong association between fasting hypertriglyceridemia and an increased risk of cardiovascular events, although there is no significant association with all-cause mortality.
Alan J Sinclair, Charles M Alexander, Michael J Davies, Changgeng Zhao, Panagiotis Mavros BMC Endocrine Disorders 2012, 12:1 (7 March 2012)
In a UK cohort, antihyperglycaemic medication was initiated in 51% of patients newly diagnosed with type 2 diabetes mellitus (T2DM) within a 2 year period following diagnosis, elevated HbA1c was the strongest factor associated with initiation of medication.